Tufts Medical Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tufts Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5162
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopathy, celiac disease, cervical cancer, epilepsy, heart disease, in vitro-fertilization, urinary incontinence, and urological cancer. It provides medical services in allergy, anesthesiology, dermatology, emergency services, internal medicine and adult primary care, weight and wellness center, and others. TMC offers advanced pediatric care to children of all ages, from babies born before their due dates to maturing adolescents. It also performs research and provides training services. TMC is headquartered in Boston, Massachusetts, the US.

Tufts Medical Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tufts Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tufts Medical Center, Medical Devices Deals, 2012 to YTD 2018 9
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tufts Medical Center, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Tracon Pharma Enters into Research Agreement with Tufts Medical Center 11
Tufts Medical Center to Form Joint Venture with Lowell General Hospital 13
Tufts Medical Center Forms Joint Venture with Aton Partners 14
Pepticom Enters into Co-Development Agreement with Tufts Medical Center 15
Tufts Medical Center, Vanguard Health And New England Quality Care Partner For New Healthcare System 16
Debt Offering 17
Tufts Medical Center Announces Public Offering Of Bonds For US$100 Million 17
Tufts Medical Center – Key Competitors 18
Tufts Medical Center – Key Employees 19
Tufts Medical Center – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 21
Recent Developments 22
Government and Public Interest 22
May 07, 2018: Tufts Clinical and Translational Science Institute (CTSI) receives $56 Million National Institutes of Health (NIH) Clinical and Translational Science Award 22
Mar 30, 2018: New Research Award by Fisher & Paykel Healthcare to Benefit COPD Patients 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Tufts Medical Center, Pharmaceuticals & Healthcare, Key Facts 2
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tufts Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tufts Medical Center, Deals By Therapy Area, 2012 to YTD 2018 8
Tufts Medical Center, Medical Devices Deals, 2012 to YTD 2018 9
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tracon Pharma Enters into Research Agreement with Tufts Medical Center 11
Tufts Medical Center to Form Joint Venture with Lowell General Hospital 13
Tufts Medical Center Forms Joint Venture with Aton Partners 14
Pepticom Enters into Co-Development Agreement with Tufts Medical Center 15
Tufts Medical Center, Vanguard Health And New England Quality Care Partner For New Healthcare System 16
Tufts Medical Center Announces Public Offering Of Bonds For US$100 Million 17
Tufts Medical Center, Key Competitors 18
Tufts Medical Center, Key Employees 19
Tufts Medical Center, Other Locations 20
Tufts Medical Center, Subsidiaries 20
Tufts Medical Center, Joint Venture 21

List of Figures
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tufts Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tufts Medical Center, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tufts Medical Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Izumi Co., Ltd.:戦略・SWOT・企業財務分析
    Izumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Izumi Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Schlumberger Ltd (SLB)-エネルギー分野:企業M&A・提携分析
    Summary Schlumberger Limited (Schlumberger) is an oilfield services company that provides technology for reservoir characterization, drilling, production, and processing to the oil and gas industry. Schlumberger also supplies the industries with products and services, from exploration through produc …
  • Air Liquide SA (AI):企業の財務・戦略的SWOT分析
    Air Liquide SA (AI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Brown & Brown, Inc.:企業のM&A・事業提携・投資動向
    Brown & Brown, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brown & Brown, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • First Quantum Minerals Ltd:企業の戦略・SWOT・財務情報
    First Quantum Minerals Ltd - Strategy, SWOT and Corporate Finance Report Summary First Quantum Minerals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Aer Lingus Ltd:企業の戦略・SWOT・財務情報
    Aer Lingus Ltd - Strategy, SWOT and Corporate Finance Report Summary Aer Lingus Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tec-Masters Inc:企業の戦略・SWOT・財務情報
    Tec-Masters Inc - Strategy, SWOT and Corporate Finance Report Summary Tec-Masters Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cimentos de Portugal SGPS SA:企業の戦略的SWOT分析
    Cimentos de Portugal SGPS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析
    Summary Adamis Pharmaceuticals Corp (Adamis) formerly Cellegy Pharmaceuticals Inc, is a bio pharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • P/F Atlantic Petroleum (ATLA DKK):企業の財務・戦略的SWOT分析
    Summary P/F Atlantic Petroleum (Atlantic Petroleum) is an oil and gas company that offers development of offshore oil projects. The company's services include exploration, appraisal, development, and production programs. It operates its oil and gas interests in the Norwegian Continental Shelf, the U …
  • Sumitomo Precision Products Co Ltd
    Sumitomo Precision Products Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Precision Products Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • National Power Corporation:企業の戦略的SWOT分析
    National Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • IDACORP, Inc.:企業の戦略・SWOT・財務分析
    IDACORP, Inc. - Strategy, SWOT and Corporate Finance Report Summary IDACORP, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • New Zealand Oil & Gas Ltd (NZO):企業の財務・戦略的SWOT分析
    Summary New Zealand Oil & Gas Ltd (NZOG) is an oil and gas exploration, development and production company. It acquires, explores, and develops crude oil and natural gas properties. NZOG’s producing assets include Maari and Manaia fields, Kupe gas and light oil field, and Sampang PSC. The company pa …
  • Huge China Holdings Limited (428):企業の財務・戦略的SWOT分析
    Huge China Holdings Limited (428) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • bioMerieux Inc:医療機器:M&Aディール及び事業提携情報
    Summary bioMerieux Inc (bioMerieux), a subsidiary of Institut Merieux SA is a provider of diagnostic solutions. The company offers its products for clinical solutions which include blood culture, cancer diagnostics, cardiovascular disease, cardiovascular pathology, clinical laboratories, companion d …
  • Cipher Pharmaceuticals Inc (CPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Cipher Pharmaceuticals Inc (Cipher) is a pharmaceutical company that develops skin care solutions. The company provides products such as actikerall, a topical solution indicated for the treatment of hyperkeratotic actinic keratosis; beteflam, a topical patch used for the treatment of mild to …
  • Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC):企業の財務・戦略的SWOT分析
    Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view …
  • Nippon Telegraph and Telephone Corporation:企業の戦略・SWOT・財務分析
    Nippon Telegraph and Telephone Corporation - Strategy, SWOT and Corporate Finance Report Summary Nippon Telegraph and Telephone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Antero Resources Corp (AR):企業の財務・戦略的SWOT分析
    Antero Resources Corp (AR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆